Lundbeck's New Partnering Focus: Link Up With Genmab On Research And Merck On Marketing Sycrest
This article was originally published in The Pink Sheet Daily
Executive Summary
Lundbeck to collaborate on CNS research with fellow Danish firm Genmab, and to exclusively market Merck's antipsychotic Sycrest outside the U.S., China and Japan.